Arvinas (ARVN) Current Assets (2017 - 2026)

Arvinas (ARVN) recorded quarterly Current Assets of $630.7 million in Q1 2026, down 9.99% quarter-over-quarter from $700.7 million in Q4 2025, and down 35.62% on a YoY basis from $979.7 million in Q1 2025.

Arvinas (ARVN) Current Assets (2017 - 2026) Analysis & Trends

Arvinas' Current Assets history runs 10 years deep, the most recent figure standing at $630.7 million for Q1 2026.

  • In Q1 2026, Current Assets fell 35.62% year-over-year to $630.7 million; the TTM figure through Mar 2026 stood at $630.7 million (down 35.62% YoY), while the FY2025 annual figure was $700.7 million, down 34.35% from the prior year.
  • Current Assets was $630.7 million for Q1 2026 at Arvinas, down from $700.7 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $1.5 billion in Q1 2022 to a low of $630.7 million in Q1 2026.
  • Historically, Current Assets has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2023.
  • The sharpest annual moves came in 2022 and 2026: Current Assets soared 119.26% in 2022, then tumbled 35.62% in 2026.
  • A 5-year view of Current Assets shows it stood at $1.2 billion in 2022, then climbed by 3.23% to $1.3 billion in 2023, then fell by 16.63% to $1.1 billion in 2024, then sank by 34.35% to $700.7 million in 2025, then fell by 9.99% to $630.7 million in 2026.
  • The last three Current Assets figures came in at $630.7 million (Q1 2026), $700.7 million (Q4 2025), and $826.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.31 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 521.86 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 10.37 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.25 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 3.59 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.63 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 11.73 Bn
9 Abivax 91.96 Bn 91.96 Bn - 600.85 Mn
10 Arvinas 492.16 Mn -122.74 Mn - 630.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 630.70 Mn
Dec 31, 2025 700.70 Mn
Sep 30, 2025 826.30 Mn
Jun 30, 2025 889.50 Mn
Mar 31, 2025 979.70 Mn
Dec 31, 2024 1.07 Bn
Sep 30, 2024 1.15 Bn
Jun 30, 2024 1.26 Bn
Mar 31, 2024 1.19 Bn
Dec 31, 2023 1.28 Bn
Sep 30, 2023 1.03 Bn
Jun 30, 2023 1.06 Bn
Mar 31, 2023 1.15 Bn
Dec 31, 2022 1.24 Bn
Sep 30, 2022 1.30 Bn
Jun 30, 2022 1.38 Bn
Mar 31, 2022 1.46 Bn
Dec 31, 2021 1.55 Bn
Sep 30, 2021 1.58 Bn
Jun 30, 2021 627.73 Mn